共 32 条
[1]
Weisz G., Leon M.B., Holmes Jr. D.R., Kereiakes D.J., Popma J.J., Teirstein P.S., Et al., Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (sirolimus-eluting stent in de novo native coronary lesions) trial, J Am Coll Cardiol, 53, pp. 1488-1497, (2009)
[2]
Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schoemig A., Et al., Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, pp. 937-948, (2007)
[3]
Stone G.W., Ellis S.G., Colombo A., Dawkins K.D., Grube E., Cutlip D.E., Et al., Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and BMS implantation, Circulation, 115, pp. 2842-2847, (2007)
[4]
Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Et al., Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, pp. 1030-1039, (2007)
[5]
Lee C.W., Kang S.J., Park D.W., Lee S.H., Kim Y.H., Kim J.J., Et al., Intravascular ultrasound findings in patients with very late thrombosis after either drug-eluting or bare-metal stent implantation, J Am Coll Cardiol, 55, pp. 1936-1942, (2010)
[6]
Cook S., Ladich E., Nakazawa G., Eshtehardi P., Neidhart M., Vogel R., Et al., Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis, Circulation, 120, pp. 391-399, (2009)
[7]
Hong M.K., Mintz G.S., Lee C.W., Kim Y.H., Lee S.W., Song J.M., Et al., Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation, Circulation, 109, pp. 881-886, (2004)
[8]
Daeman J., Tanimoto S., Garcia-Garcia H.M., Kukreja N., van de Sande M., Sianos G., Et al., Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries), Am J Cardiol, 99, pp. 1027-1032, (2007)
[9]
Fajadet J., Morice M.C., Bode C., Barragan P., Serruys P.W., Wijns W., Et al., Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial, Circulation, 111, pp. 1040-1044, (2005)
[10]
Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 349, pp. 1315-1323, (2003)